Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 1
2010 1
2012 1
2013 1
2015 2
2016 4
2017 4
2018 4
2019 3
2020 7
2021 1
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy with drugs.
Choi Y, Diefenbach CS. Choi Y, et al. Among authors: diefenbach cs. Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):598-605. doi: 10.1182/hematology.2020000146. Hematology Am Soc Hematol Educ Program. 2020. PMID: 33275686 Free PMC article. Review.
Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.
Diefenbach CS, Connors JM, Friedberg JW, Leonard JP, Kahl BS, Little RF, Baizer L, Evens AM, Hoppe RT, Kelly KM, Persky DO, Younes A, Kostakaglu L, Bartlett NL. Diefenbach CS, et al. J Natl Cancer Inst. 2016 Dec 31;109(4):djw249. doi: 10.1093/jnci/djw249. Print 2017 Apr. J Natl Cancer Inst. 2016. PMID: 28040700 Free PMC article. Review.
Polatuzumab Vedotin: a New Target for B Cell Malignancies.
Choi Y, Diefenbach CS. Choi Y, et al. Among authors: diefenbach cs. Curr Hematol Malig Rep. 2020 Apr;15(2):125-129. doi: 10.1007/s11899-020-00572-7. Curr Hematol Malig Rep. 2020. PMID: 32172360 Review.
KLRG1, Another Opportunity for a Breakthrough in MTCL.
Varma G, Diefenbach CS. Varma G, et al. Among authors: diefenbach cs. Clin Cancer Res. 2024 Apr 3. doi: 10.1158/1078-0432.CCR-24-0374. Online ahead of print. Clin Cancer Res. 2024. PMID: 38568191
Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma.
Younes A, Burke JM, Cheson BD, Diefenbach CS, Ferrari S, Hahn UH, Hawkes EA, Khan C, Lossos IS, Musuraca G, Tani M, Vitolo U, Yuen S, Raval A, Shivhare M, Nielsen TG, Sellam G, Sharman JP. Younes A, et al. Among authors: diefenbach cs. Blood Adv. 2023 Apr 25;7(8):1488-1495. doi: 10.1182/bloodadvances.2022008344. Blood Adv. 2023. PMID: 36287231 Free PMC article. Clinical Trial.
32 results